One undervalued dividend stock I’d buy over Centrica plc

Centrica plc (LON: CNA) looks to be a great dividend stock, but here’s why I’m avoiding it.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At first glance, Centrica (LSE: CNA) looks to be a top dividend stock. The utility company is highly defensive, and the shares support a dividend yield of 6.9%. The payout is covered 1.3 times by earnings per share, so it does not look as if management will be forced to cut it any time soon. 

However, while Centrica might look attractive at first glance, I’m avoiding this high-yield play in favour of another dividend champion. 

Risky business

The supply and distribution of gas and electricity shouldn’t be a risky business. The amount of power the world is consuming is growing every day, and it takes an enormous amount of financial firepower to set up new power generation facilities, giving the industry high barriers to entry. 

Unfortunately, politicians are now starting to interfere in the market and these actions have dramatically increased the risks of operating in the sector. Energy price cap threats have sent shares in Centrica down by almost 50% over the past five years, and the company has already been forced to cut its dividend. 

It’s impossible to tell what the future holds for the energy industry, but it’s unlikely the operating environment is going to get any easier. With this being the case, I believe Centrica’s dividend is under threat once again. Dividend cover of 1.3 is not enough of a cushion to protect against a further deterioration in earnings.  

As well as political issues, Centrica is also struggling to attract customers. During the first half, the group lost 387,000 account holders, but a 12.5% increase in domestic energy prices helped cushion a decline in earnings. Adjusted group earnings fell 11% for the period, and the operating margin of the UK Home division slipped from 12.7% last time to 11%. 

Price hikes are one way of offsetting customer exits, but the company’s use of this tactic will be limited. If prices continue to rise, customers will only exit faster, and higher prices will embolden policymakers to clamp down. Put simply, the firm is stuck between a rock and a hard place. 

Upward trajectory 

Compared to Centrica, Man Group (LSE: EMG) looks to me to be a much better buy. The company’s potential is not being constricted by politics and demand for its services is growing not shrinking.

In a trading update published today, Man announced that funds under management had increased to $103.5bn at 30 September, up 28% year to date. Net inflows of $2.8bn, investment gains of $3.3bn and FX movements all helped contribute to the positive performance. 

Off the back of these gains, City analysts are expecting the company to report earnings per share growth of 45% for 2017, followed by growth of 26% for 2018. Following this increase, analysts have pencilled in a dividend of 7.5p per share for this year, and 8.5p for 2018 — growth of 25% in two years. Based on these projections, the shares support a dividend yield of 4.4%, and the payout is covered 1.6 times by earnings per share. 

As well as the annual dividend, Man’s management has put a share repurchase plan in place. A $100m repurchase has been given the green light, and the group has around $275m in excess capital (excluding the buyback), which could also be distrubuted. 

Overall, I believe Man’s growing earnings, dividend and buybacks show that the group is a much better income buy than Centrica. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »